Compare GIFI & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIFI | WGSWW |
|---|---|---|
| Founded | 1985 | 2017 |
| Country | United States | United States |
| Employees | N/A | 1000 |
| Industry | Metal Fabrications | Retail: Computer Software & Peripheral Equipment |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 188.5M | N/A |
| IPO Year | 1997 | N/A |
| Metric | GIFI | WGSWW |
|---|---|---|
| Price | $11.92 | $0.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 104.9K | 36.6K |
| Earning Date | 11-12-2025 | 02-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | $166,767,000.00 | ★ $305,450,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.58 | ★ N/A |
| Revenue Growth | 0.26 | ★ 50.79 |
| 52 Week Low | $5.75 | $0.17 |
| 52 Week High | $12.00 | $0.21 |
| Indicator | GIFI | WGSWW |
|---|---|---|
| Relative Strength Index (RSI) | 89.12 | 39.80 |
| Support Level | $11.82 | $0.04 |
| Resistance Level | $11.79 | $0.06 |
| Average True Range (ATR) | 0.04 | 0.01 |
| MACD | -0.15 | -0.00 |
| Stochastic Oscillator | 65.22 | 21.85 |
Gulf Island Fabrication Inc is a U.S. based company that is a fabricator of complex steel structures and marine vessels. The company also provides installation, hook-up, commissioning, repair, and maintenance services with specialized crews. The company operates through segments namely Fabrication division which fabricates structures such as offshore drilling and production platforms and other steel structures for customers in the oil and gas industries; the Shipyards division manufactures newly built and repairs various steel marine vessels in the United States; the Services division provides interconnect piping services on offshore platforms, welding, and inshore structures and also provides maintenance and industrial facilities. Majority revenue is from services segment.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.